Search results for "436"

showing 7 items of 117 documents

In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy

2004

LDL can be subfractionated into buoyant (1.020-1.029 g/ml(-1)), intermediate (1.030-1.040 g/ml(-1)), and dense (1.041-1.066 g/ml(-1)) LDLs. We studied the rebound of these LDL-subfractions after LDL apheresis in seven patients with heterozygous familial hypercholesterolemia (FH) regularly treated by apheresis (58 +/- 9 years, LDL-cholesterol = 342 +/- 87 mg/dl(-1), triglycerides = 109 +/- 39 mg/dl(-1)) and high-dose statins. Apolipoprotein B (apoB) concentrations were measured in LDL subfractions immediately after and on days 1, 2, 3, 5, and 7 after apheresis. Compartmental models were developed to test three hypotheses: 1) that dense LDLs are derived from the delipidation of buoyant and in…

medicine.medical_specialtyVery low-density lipoproteinApolipoprotein Blow density lipoprotein metabolismFamilial hypercholesterolemiaQD415-436Biochemistrychemistry.chemical_compoundEndocrinologyInternal medicinerebound kineticsmedicinesmall dense low density lipoproteinsdensity gradient ultracentrifugationbiologyfamilial hypercholesterolemiaChemistryCholesterollow density lipoprotein subtypesCell BiologyMetabolismmedicine.diseaseEndocrinologyApheresisLDL apheresisbiology.proteinDensity gradient ultracentrifugationlipids (amino acids peptides and proteins)Journal of Lipid Research
researchProduct

Statins stimulate the production of a soluble form of the receptor for advanced glycation end products

2013

The beneficial effects of statin therapy in the reduction of cardiovascular pathogenesis, atherosclerosis, and diabetic complications are well known. The receptor for advanced glycation end products (RAGE) plays an important role in the progression of these diseases. In contrast, soluble forms of RAGE act as decoys for RAGE ligands and may prevent the development of RAGE-mediated disorders. Soluble forms of RAGE are either produced by alternative splicing [endogenous secretory RAGE (esRAGE)] or by proteolytic shedding mediated by metalloproteinases [shed RAGE (sRAGE)]. Therefore we analyzed whether statins influence the production of soluble RAGE. Lovastatin treatment of either mouse alveol…

medicine.medical_specialtyendocrine system diseasesADAM10Receptor for Advanced Glycation End ProductsBeta-CyclodextrinsQD415-436PharmacologyBiochemistryCell LineRAGE (receptor)MiceEndocrinologyGlycationInternal medicinediabetic complicationsmedicineAnimalsHumansSecretionLovastatincardiovascular diseasesReceptors ImmunologicReceptorResearch ArticlesDose-Response Relationship DrughypercholesterolemiaChemistrybeta-CyclodextrinsHEK 293 cellsTricarboxylic Acidsnutritional and metabolic diseasesCell BiologyBridged Bicyclo Compounds HeterocyclicADAM 10CholesterolFarnesyl-Diphosphate FarnesyltransferaseEndocrinologySolubilitycardiovascular systemLovastatinHydroxymethylglutaryl-CoA Reductase Inhibitorsatherosclerosishuman activitiesmedicine.drugJournal of Lipid Research
researchProduct

In Silico Analysis of Microarray-Based Gene Expression Profiles Predicts Tumor Cell Response to Withanolides

2012

Withania somnifera (L.) Dunal (Indian ginseng, winter cherry, Solanaceae) is widely used in traditional medicine. Roots are either chewed or used to prepare beverages (aqueous decocts). The major secondary metabolites of Withania somnifera are the withanolides, which are C-28-steroidal lactone triterpenoids. Withania somnifera extracts exert chemopreventive and anticancer activities in vitro and in vivo. The aims of the present in silico study were, firstly, to investigate whether tumor cells develop cross-resistance between standard anticancer drugs and withanolides and, secondly, to elucidate the molecular determinants of sensitivity and resistance of tumor cells towards withanolides. Usi…

natural productsIn silicoBiomedical EngineeringBioengineeringmedicinal foodWithania somniferaPharmacologyBiochemistryArticleTranscriptomelcsh:Biochemistrychemistry.chemical_compoundGene expressioncancerlcsh:QD415-436Transcription factorpharmacogenomicsbiologybiology.organism_classificationdrug developmentchemistryCell cultureWithaferin ASignal transductionmicroarrayBiotechnologyMicroarrays
researchProduct

Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis.

2003

Inflammation underlies both onset and perpetuation of atherosclerosis. Plasma lipoproteins transport the platelet-activating factor-acetylhydrolase (PAF-AH) with potentially anti-inflammatory activities. Our aim was to determine whether PAF-AH activity was associated with inflammatory markers and with coronary artery disease (CAD). PAF-AH activity and a panel of inflammatory mediators were measured in plasma of 496 patients with CAD and in 477 controls; 276 patients presented with stable angina pectoris and 220 with acute coronary syndrome (ACS). Individuals within the highest quartile of PAF-AH activity had an 1.8-fold increase in CAD risk [95% confidence interval (CI), 1.01 to 3.2; P = 0.…

platelet-activating factorAdultMaleRiskmedicine.medical_specialtyAcute coronary syndromePAF acetylhydrolaseStatinCross-sectional studymedicine.drug_classMutation MissenseInflammationAngiotensin-Converting Enzyme InhibitorsQD415-436Coronary Artery DiseaseBiochemistryCoronary artery diseaseEndocrinologySex FactorsRisk FactorsInternal medicinemedicineHumansAgedInflammationbusiness.industryCell BiologySyndromeMiddle Agedmedicine.diseaseConfidence intervalCross-Sectional StudiesQuartile1-Alkyl-2-acetylglycerophosphocholine EsteraseAcute DiseaseCardiologylipids (amino acids peptides and proteins)Femaleatherosclerosismedicine.symptombusinessJournal of lipid research
researchProduct

Sobre la identidad y procedencia del poeta Filóxeno y la autoría del ditirambo ???????

2019

El presente estudio pretende resolver la controversia en torno a la identidad y procedencia del poeta Filóxeno, célebre ditirambógrafo del siglo V-IV a.C. Para ello, hemos recopilado todos los testimonios que citan a personajes con el nombre de Filóxeno desde la primera mención de Aristófanes. La investigación ha revelado que existen varios individuos con el mismo nombre y rasgos comunes. No obstante, el examen de estos testimonios revela la existencia de un único autor de ditirambos: Filóxeno de Citera. Además, creemos que este poeta fue el autor del ditirambo ???????, que algunos editores atribuyeron falsamente a Filóxeno de Léucade. Posteriormente, reflexionamos sobre la identidad de Fil…

reflexionamos sobre la identidad de Filóxeno de Léucadequien probablemente debamos identificar con Filóxeno de CiteraUNESCO::CIENCIAS DE LAS ARTES Y LAS LETRAS//pages.uv.es/SPhV/cas/numero21.wiki [Philoxenus of Cythera ? Philoxenus of Leucas ? Pseudoepigraphy ? Dithyramb ? Athenaeus of Naucratis 165 189 https]el examen de estos testimonios revela la existencia de un único autor de ditirambos: Filóxeno de Citera. Ademásy la autoría de una ?????????. Finalmentededicaremos unas últimas consideraciones sobre Filóxeno Pternokopides. Filóxeno de Citera ? Filóxeno de Léucade ? Pseudoepigrafía ? Ditirambo ? Ateneo de Náucratishemos recopilado todos los testimonios que citan a personajes con el nombre de Filóxeno desde la primera mención de Aristófanes. La investigación ha revelado que existen varios individuos con el mismo nombre y rasgos comunes. No obstanteJuan B. El presente estudio pretende resolver la controversia en torno a la identidad y procedencia del poeta Filóxeno:CIENCIAS DE LAS ARTES Y LAS LETRAS [UNESCO]que algunos editores atribuyeron falsamente a Filóxeno de Léucade. Posteriormentecélebre ditirambógrafo del siglo V-IV a.C. Para elloPhiloxenus of Cythera ? Philoxenus of Leucas ? Pseudoepigraphy ? Dithyramb ? Athenaeus of Naucratis 165 189 https://pages.uv.es/SPhV/cas/numero21.wiki1135-9560 8276 Studia philologica valentina 536436 2019 21 7225819 Sobre la identidad y procedencia del poeta Filóxeno y la autoría del ditirambo ??????? Juan-LópezFilóxeno de Citera. Además [el examen de estos testimonios revela la existencia de un único autor de ditirambos]creemos que este poeta fue el autor del ditirambo ???????
researchProduct

Aristóteles entre doxografía y biografía: sobre Diógenes Laercio V 31

2019

Se pretende llamar la atención sobre un par de frases que aparecen justo hacia la mitad de la controvertida doxografía de Aristóteles que se puede leer en las Vidas y doctrinas de los filósofos más ilustres de Diógenes Laercio V 31, y que desde luego no corresponden a ningún sistema doxográfico conocido. Como sucede no pocas veces en la obra laerciana, la misma apreciación sobre si el filósofo debe o no enamorarse y contraer matrimonio se repite idéntica en otras doxografías completamente distintas: la cirenaica (DL II 91), la estoica (DL VII 129) y la epicúrea (DL X 118). Cabe plantearse, pues, el origen de este interés, en varias doxografías, por la vida sentimental, podríamos decir, de l…

sobre Diógenes Laercio V 31 Grau Guijarro [1135-9560 8276 Studia philologica valentina 536436 2019 21 7225817 Aristóteles entre doxografía y biografía]of the philosophersBiografies clàssiquesClassical biographiesFilòsofs -- Grèciaas well as the statements about whether the philosopher should live in the court of the powerful. Diógenes Laercio ? doxografía filosófica ? biografía griega antigua de filósofos ? vida de AristótelesFilosofia gregaAncient philosophersthe Cyrenaic (DL II 91) [completely different doxographies]90 - Arqueologia. Prehistòriacompletely different doxographies: the Cyrenaic (DL II 91)the Stoic (DL VII 129) and the Epicurean (DL X 118). It is possible to considerit is interesting to ask whether it could be a biographical topic transferred to doxographySergi It is intended to draw attention to a couple of phrases that appear right towards the middle of Aristotle?s controversial doxography that can be read in the Lives and doctrines of the most illustrious philosophers by Diogenes Laertius V 31Filòsofs anticsGreek philosophyDiogenes Laertius ? philosophical doxography ? ancient Greek biography of philosophers ? Aristotle?s life 133 147 https://pages.uv.es/SPhV/cas/numero21.wikiUNESCO::CIENCIAS DE LAS ARTES Y LAS LETRASand which certainly do not correspond to any known doxographic system. As it frequently happens in the Laercian work//pages.uv.es/SPhV/cas/numero21.wiki [Diogenes Laertius ? philosophical doxography ? ancient Greek biography of philosophers ? Aristotle?s life 133 147 https]1135-9560 8276 Studia philologica valentina 536436 2019 21 7225817 Aristóteles entre doxografía y biografía: sobre Diógenes Laercio V 31 Grau GuijarroFilosofia antigathen:CIENCIAS DE LAS ARTES Y LAS LETRAS [UNESCO]the origin of this interest in the sentimental lifein several doxographies. Once it has been established that its presence can hardly be traced in the philosophers? own doctrineswe could saythe same consideration about whether or not the philosopher should fall in love and get married is identical in other
researchProduct

A Novel Pathophysiological Mechanism Contributing to Trigeminal Neuralgia

2016

Trigeminal neuralgia (TN) is a form of neuropathic pain that affects the fifth cranial nerve, the most widely distributed nerve in the head. Although TN has been associated with a variety of pathological conditions, neurovascular compression on the trigeminal nerve, as it exits the brain stem, is the most frequent reported cause. This compression provides a progressive demyelination of the nerve and a subsequent aberrant neural transmission. Although several studies have clarified some physiopathological mechanisms underlying TN, the molecular basis remains vague. Very recently the substitution of methionine 136 by valine (MET126Val) in sodium channel Nav1.6 in a case study of typical TN ha…

trigeminal ganglionlcsh:Biochemistry03 medical and health sciencesTrigeminal ganglion0302 clinical medicineaction potentialTrigeminal neuralgianeurovascualr compressionGeneticsmedicinelcsh:QD415-436Molecular BiologyPathologicalTrigeminal neuralgia; action potential; molecular mechanism; neurovascualr compression; trigeminal ganglionGenetics (clinical)Trigeminal nervebusiness.industrySodium channellcsh:RM1-950medicine.diseasePathophysiologylcsh:Therapeutics. Pharmacology030220 oncology & carcinogenesisAnesthesiaNeuropathic painMolecular MedicineBrainstemmolecular mechanismbusinessNeuroscience030217 neurology & neurosurgeryTrigeminal neuralgiaResearch Article
researchProduct